12.02.2014 - EU rules dating from 2007, allowing pharmaceutical companies to opt out of pediatric trials with new cancer medicines if the disease they are intended to treat rarely affects...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)